Ming Xu

机构：Shandong University of Aeronautics, Shanghai Jiao Tong University, Shantou University, Affiliated Hospital of Southwest Medical University, Cancer Hospital of Shantou University Medical College, Tongren Hospital, Jiangsu Provincial Center for Disease Control and Prevention, Shanghai Sixth People's Hospital, Shanghai Clinical Research Center · ORCID：0009-0005-1536-8427

发表论文 33 篇 · 总被引 319 次 · h-index 9

代表论文

• Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study (2023 · Journal of Gastroenterology · 被引 38)
• Pseudomonas aeruginosa targeting cascade photodynamic nanoassemblies for efficient antibacterial and anti-inflammatory therapy (2023 · Nano Today · 被引 28)
• Noncovalent co-assembly of aminoglycoside antibiotics@tannic acid nanoparticles for off-the-shelf treatment of pulmonary and cutaneous infections (2023 · Chemical Engineering Journal · 被引 19)
• Dynamic phenotypes of preclinical and clinical obesity in relation to new‐onset cancer risk: A longitudinal analysis from the UK biobank (2025 · Diabetes Obesity and Metabolism · 被引 11)
• Cardiovascular-kidney-metabolic syndrome stages and increased risk of all-cause and cause-specific mortality in UK Biobank (2025 · American Journal of Preventive Cardiology · 被引 9)
• Contributions of Clinical Obesity and Preclinical Obesity to the All‐Cause Mortality Risk: Findings From the UK Biobank Cohort (2025 · Diabetes/Metabolism Research and Reviews · 被引 9)